| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,512 |
13,698 |
$840K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,952 |
5,908 |
$509K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
231 |
183 |
$461K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
727 |
574 |
$397K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,322 |
9,002 |
$345K |
| 99215 |
Prolong outpt/office vis |
4,796 |
3,552 |
$316K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
43,513 |
32,134 |
$202K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,712 |
4,235 |
$160K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
729 |
520 |
$132K |
| 96367 |
|
5,600 |
3,651 |
$117K |
| 80053 |
Comprehensive metabolic panel |
21,511 |
16,241 |
$104K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,459 |
7,220 |
$84K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
643 |
450 |
$48K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
486 |
392 |
$48K |
| 36415 |
Collection of venous blood by venipuncture |
25,441 |
19,883 |
$33K |
| 82728 |
|
3,411 |
2,950 |
$26K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,380 |
987 |
$20K |
| 83550 |
|
1,771 |
1,556 |
$10K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
186 |
50 |
$9K |
| 96417 |
|
211 |
152 |
$9K |
| 83540 |
|
1,772 |
1,556 |
$7K |
| 83735 |
|
1,632 |
1,120 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
735 |
494 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
72 |
57 |
$5K |
| 96415 |
|
192 |
126 |
$4K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
36 |
27 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
185 |
114 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,744 |
2,383 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
54 |
24 |
$1K |
| 99443 |
|
15 |
13 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
4,670 |
3,686 |
$994.32 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
296 |
263 |
$731.36 |
| 90674 |
|
104 |
84 |
$394.52 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
25 |
$291.72 |
| J9190 |
Injection, fluorouracil, 500 mg |
15 |
12 |
$205.01 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
167 |
51 |
$64.68 |
| 81001 |
|
12 |
12 |
$36.99 |
| J3490 |
Unclassified drugs |
39 |
25 |
$0.60 |
| J9271 |
Injection, pembrolizumab, 1 mg |
16 |
12 |
$0.03 |
| J9999 |
Not otherwise classified, antineoplastic drugs |
360 |
254 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
54 |
53 |
$0.00 |